Enhancement of cutaneous immunity during ageing by blocking p38 MAPkinase induced inflammation

Capsule summary: Elevated cutaneous inflammation retards VZV-specific immunity. Inhibiting inflammatory cytokine production with p38 MAPkinase inhibitors enhances VZV-specific cutaneous immunity. Targeting inflammation may be used to promote vaccine efficacy and the treatment of malignancy during ageing.

http://ift.tt/2inJj1p